Ju. Igietseme et al., AN IN-VITRO MODEL FOR IMMUNE CONTROL OF CHLAMYDIAL GROWTH IN POLARIZED EPITHELIAL-CELLS, Infection and immunity, 62(8), 1994, pp. 3528-3535
A polarized epithelial culture system and chlamydia-specific T-cell fi
nes and clones were employed to investigate the ability and mechanisms
by which T cells control the growth of chlamydiae in epithelial cells
. Monolayers of polarized mouse epithelial cells were infected with th
e Chlamydia trachomatis agent of mouse pneumonitis (MoPn) and then exp
osed to antigen-stimulated MoPn-specific T-cell lines and clones. The
results revealed that in vivo-protective MoPn-specific T-cell lines an
d clone 2.14-0 were capable of inhibiting the growth of MoPn in polari
zed epithelial tells. In contrast, the nonprotective MoPn-specific T-c
ell clone 2.14-3, naive splenic T cells, and a control T-cell clone co
uld not inhibit the growth of MoPn in epithelial cells. Transmission e
lectron microscopic analysis of infected epithelial cells which were e
xposed to clone 2.14-0 confirmed the absence of an established infecti
on, as deduced from the virtual absence of inclusions in the cells. An
tigen-specific activation of clone 2.14-0 was required for the MoPn-in
hibitory function, since the absence of antigenic stimulation or stimu
lation with a heterologous chlamydial agent did not result in MoPn gro
wth inhibition. Activation of clone 2.14-0 resulted in acquisition of
the capacity to inhibit growth of both homologous (MoPn) and heterolog
ous chlamydial agents. Close interaction between epithelial cells and
clone 2.14-0 was required for the MoPn-inhibitory action, because sepa
ration of the cell types by a filter with a pore size of 0.45, 3.0, or
even 8.0 mu m abrogated MoPn inhibition. Protective T cells may act a
t close range in the epithelium to control chlamydial growth, possibly
involving short-range-acting cytokines. The ability of antigen-stimul
ated T-cell lines and clones to inhibit chlamydial growth in polarized
epithelial cultures could be a useful method for identifying protecti
ve T-cell clones and antigenic peptide fragments containing protective
epitopes.